(Deamino-Cys11,D-2-Nal14,Cys18)-β-MSH (11-22) amide is a modified β-melanocyte-stimulating hormone (MSH) with deamino and D-2-naphthylalanine substitutions that enhance stability and receptor binding. The peptide is involved in regulating skin pigmentation and energy homeostasis. Researchers use it to explore the role of melanocortin receptors in these processes and to study the impact of modifications on peptide function.
CAT No: M2724
CAS No:436083-30-6
Synonyms/Alias:(Deamino-Cys11,D-2-Nal14,Cys18)-β-MSH (11-22) amide;JKC-363
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.